GTBP
$2.75
GT Biopharma
$.15
5.77%
GTBP
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($0.18)
Revenue:  N/A
Thursday
Nov 10
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when GTBP reports earnings?
Beat
Meet
Miss

Where is GTBP's stock price going from here?
Up
Flat
Down
Stock chart of GTBP
Analysts
Summary of analysts' recommendations for GTBP
Score
Grade
Pivots
Resistance
$3.20
$3.00
$2.87

$2.67

Support
$2.54
$2.34
$2.21
Tweet
Growth
Description
GT Biopharma Inc. is an immuno-oncology company. It discovers, develops and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions and other unmet medical needs. GT Biopharma Inc., formerly known as OXIS International Inc., is based in Tampa, Florida.